compound, methods for treating atherosclerosis, for increasing hdl-c, for reducing p ldl-c and for treating dyslipidemia in a patient, and, use of compound, pharmaceutical composition

摘要

Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.